
  
    
      
        Background
        The normal function of transforming growth factor β 
        <NUMEX TYPE="CARDINAL">1</NUMEX> (TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> ) is essential for the entire
        <ENAMEX TYPE="PERSON">organism</ENAMEX>, representing a multifunctional <ENAMEX TYPE="PER_DESC">regulator</ENAMEX> of cell
        growth and differentiation [ <NUMEX TYPE="CARDINAL">1 2 3 4 5</NUMEX> ] . TGFβ 
        <ENAMEX TYPE="PRODUCT">1</ENAMEX> is a potent inhibitor of epithelial
        cell proliferation. Upon binding of TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> , TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -<ENAMEX TYPE="SUBSTANCE">receptors phosphorylate SMAD2</ENAMEX> or
        SMAD3 [ <NUMEX TYPE="CARDINAL">6 7 8 9 10 11 12</NUMEX> ] . <ENAMEX TYPE="ORGANIZATION">Phosphorylated</ENAMEX> <NUMEX TYPE="CARDINAL">SMAD2/3</NUMEX>
        <ENAMEX TYPE="PER_DESC">associates</ENAMEX> with <ENAMEX TYPE="PRODUCT">SMAD4</ENAMEX> and, as a complex, moves into the
        <ENAMEX TYPE="PERSON">nucleus</ENAMEX>, where it regulates gene expression [ <NUMEX TYPE="CARDINAL">13 14 15</NUMEX> ]
        .
        SMAD4 (<NUMEX TYPE="MONEY">DPC4</NUMEX>) is essential for this TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> signaling and transcriptional
        activation process [ <TIMEX TYPE="DATE">16</TIMEX> ] . In epithelial cells, TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> decreases c-myc, <ENAMEX TYPE="PRODUCT">cdc2</ENAMEX> and <ENAMEX TYPE="SUBSTANCE">cyclin</ENAMEX> D1
        expression, and it increases the expression of c-jun and
        c-fos [ <NUMEX TYPE="CARDINAL">17 18 19 20 21 22 23</NUMEX> ] . Activation of the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> signal pathway in epithelial cells
        leads to an increased expression of the cell cycle
        <ENAMEX TYPE="CONTACT_INFO">inhibitors p21 WAF1and p15 Ink4band</ENAMEX> to a release of
        formerly sequestered <ENAMEX TYPE="PRODUCT">p27 KIP</ENAMEX> [ <NUMEX TYPE="CARDINAL">24 25 26</NUMEX> ] . It is assumed
        that the cooperative action of these cell cycle inhibitors
        results in the growth arrest mentioned above, although p15
        Ink4bdoes not seem to be necessary in this regard. In
        addition to mutations in the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -<ENAMEX TYPE="SUBSTANCE">receptors</ENAMEX>, in a large number of
        carcinomas disruptions of this signaling pathway by the
        alteration of a single <ENAMEX TYPE="SUBSTANCE">protein</ENAMEX> such as <ENAMEX TYPE="PRODUCT">p15 Ink4b</ENAMEX>, <TIMEX TYPE="DATE">p16</TIMEX>, and
        p21 <ENAMEX TYPE="ORGANIZATION">Waf1are</ENAMEX> found [ <NUMEX TYPE="CARDINAL">2 27 28 29 30 31 32 33 34 35 36 37 38</NUMEX>
        <NUMEX TYPE="CARDINAL">39</NUMEX> ] . This may result in resistance to the
        growth-inhibiting action of TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> .
        In several cell lines, particularly in pancreatic
        carcinoma cells, resistance to TGFβ 
        <ENAMEX TYPE="PRODUCT">1</ENAMEX> could be attributed to a loss of
        function of <TIMEX TYPE="DATE">the SMAD4</TIMEX> (<NUMEX TYPE="MONEY">DPC4</NUMEX>) <ENAMEX TYPE="SUBSTANCE">protein</ENAMEX> [ <NUMEX TYPE="CARDINAL">40 41 42 43</NUMEX> ] .
        However, the pancreatic carcinoma cell line <ENAMEX TYPE="PRODUCT">BxPC-3</ENAMEX>,
        although homozygously deleted for <TIMEX TYPE="DATE">SMAD4</TIMEX>, is growth
        inhibited by TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> [ <NUMEX TYPE="CARDINAL">30 44</NUMEX> ] . It is thus speculated that
        alternative signaling pathways in addition to the SMAD
        pathway may exist.
        After binding to α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin, latent TGFβ 
        <ENAMEX TYPE="PRODUCT">1</ENAMEX> is activated by processing of latent
        TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> by cleavage of the latency-associated
        <ENAMEX TYPE="ORGANIZATION">Peptide</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">LAP</ENAMEX>) [ <NUMEX TYPE="CARDINAL">45 46 47 48 49 50 51 52 53 54 55 56 57</NUMEX> ] .
        Recently, the interaction of latent TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> with α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin has been shown [ <TIMEX TYPE="DATE">45</TIMEX> ] . After
        binding of latent TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> to α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin, latent TGFβ 
        <ENAMEX TYPE="PRODUCT">1</ENAMEX> is activated by cleavage of the
        latency-associated peptide (<ENAMEX TYPE="ORGANIZATION">LAP</ENAMEX>) [ <TIMEX TYPE="DATE">45</TIMEX> ] . This α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin is also expressed by
        pancreatic carcinoma cells [ <NUMEX TYPE="CARDINAL">58 59 60 61 62 63</NUMEX> ] . We
        hypothesized that there is a <ENAMEX TYPE="ORGANIZATION">SMAD</ENAMEX>-independent TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> signaling pathway in TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -sensitive carcinoma cells. To address
        this question, several carcinoma cell lines with different
        degrees of TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> sensitivity were chosen as a model
        system. We investigated the interaction of TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> with the α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin and its influence on selected
        target genes known to be involved in cell cycle-regulated
        growth inhibition. Here, we demonstrate an alternate TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> signaling pathway via α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> <ENAMEX TYPE="PER_DESC">integrin</ENAMEX> contributing to TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> growth inhibiton in TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> sensitive carcinoma cells.
      
      
        Results
        
          <ENAMEX TYPE="ORGANIZATION">Mature TGFβ</ENAMEX> <ENAMEX TYPE="PRODUCT">1induces</ENAMEX> cytoskeletal immobilization of
          <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> and tyrosine phosphorylation via integrin α Vβ
          6only in <ENAMEX TYPE="ORGANIZATION">TGFβ</ENAMEX> <ENAMEX TYPE="PRODUCT">1sensitive</ENAMEX> cells
          Only integrins that have bound their ligands are
          anchored to the cytoskeleton [ <NUMEX TYPE="CARDINAL">64 65</NUMEX> ] . In our
          experiments, mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> , α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> integrin, and <ENAMEX TYPE="PRODUCT">F-</ENAMEX>actin colocalize
          (Figure <NUMEX TYPE="CARDINAL">1</NUMEX>), suggesting association with and activation of
          this integrin. To further support this finding, we
          stimulated cells and performed co-immunoprecipitated
          various integrin subunits of cytoskeletal anchored
          <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> [ <NUMEX TYPE="CARDINAL">66 67</NUMEX> ] (additional file <ENAMEX TYPE="CONTACT_INFO">1, 2, 3and 4</ENAMEX>). Our
          <ENAMEX TYPE="ORGANIZATION">data</ENAMEX> strongly suggest that mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> <ENAMEX TYPE="PER_DESC">associates</ENAMEX> with α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <TIMEX TYPE="TIME">6 integrin</TIMEX> (additional file <ENAMEX TYPE="CONTACT_INFO">1, 2,</ENAMEX> 3and
          <NUMEX TYPE="CARDINAL">4</NUMEX>).
          Additional File 1
          <ENAMEX TYPE="ORGANIZATION">Portable Network Graphic</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">PNG</ENAMEX>) File showing that
          mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> binds to α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <TIMEX TYPE="TIME">6 integrin.</TIMEX> The <ENAMEX TYPE="SUBSTANCE">cells</ENAMEX> indicated were
          stimulated for <TIMEX TYPE="TIME">ten minutes</TIMEX> with <NUMEX TYPE="CARDINAL">10</NUMEX> nM of either mature
          TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> , tumor necrosis <ENAMEX TYPE="SUBSTANCE">factor α</ENAMEX> (TNFα) or
          <ENAMEX TYPE="ORGANIZATION">fibronectin</ENAMEX> (FN). Cytoskeletal anchored <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> were
          <ENAMEX TYPE="PERSON">extracted</ENAMEX>, co-immunoprecipitated (IP) and analyzed (<ENAMEX TYPE="PERSON">Blot</ENAMEX>)
          with the <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> indicated.
          Click here for file
          Additional File 2
          <ENAMEX TYPE="ORGANIZATION">Portable Network Graphic</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">PNG</ENAMEX>) File showing that
          mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> binds to α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <TIMEX TYPE="TIME">6 integrin.</TIMEX> The <ENAMEX TYPE="SUBSTANCE">cells</ENAMEX> indicated were
          stimulated for <TIMEX TYPE="TIME">ten minutes</TIMEX> with <NUMEX TYPE="CARDINAL">10</NUMEX> nM of either mature
          TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> , tumor necrosis <ENAMEX TYPE="SUBSTANCE">factor α</ENAMEX> (TNFα),
          laminin-1 (<NUMEX TYPE="MONEY">Lam1</NUMEX>) or fibronectin (FN). Cytoskeletal
          <ENAMEX TYPE="SUBSTANCE">anchored proteins</ENAMEX> were extracted, co-immunoprecipitated
          (<ENAMEX TYPE="ORGANIZATION">IP</ENAMEX>) and analyzed (<ENAMEX TYPE="PERSON">Blot</ENAMEX>) with the antibodies
          indicated.
          Click here for file
          Additional File 3
          <ENAMEX TYPE="ORGANIZATION">Portable Network Graphic</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">PNG</ENAMEX>) File showing that
          mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> binds to α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> integrin and the speciticity of the
          signals detected as well. The <ENAMEX TYPE="SUBSTANCE">cells</ENAMEX> indicated were
          stimulated for <TIMEX TYPE="TIME">ten minutes</TIMEX> with <NUMEX TYPE="CARDINAL">10</NUMEX> nM of either mature
          TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> , tumor necrosis <ENAMEX TYPE="SUBSTANCE">factor α</ENAMEX> (TNFα), or
          <ENAMEX TYPE="ORGANIZATION">fibronectin</ENAMEX> (FN). Cytoskeletal anchored <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> were
          <ENAMEX TYPE="PERSON">extracted</ENAMEX>, co-immunoprecipitated (IP) and analyzed (<ENAMEX TYPE="PERSON">Blot</ENAMEX>)
          with the <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> indicated.
          Click here for file
          Additional File 4
          <ENAMEX TYPE="ORGANIZATION">Portable Network Graphic</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">PNG</ENAMEX>) File showing the
          speciticity of the signals detected. The <ENAMEX TYPE="SUBSTANCE">cells</ENAMEX> indicated
          were stimulated for <TIMEX TYPE="TIME">ten minutes</TIMEX> with <NUMEX TYPE="CARDINAL">10</NUMEX> nM of either
          mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> , tumor necrosis <ENAMEX TYPE="SUBSTANCE">factor α</ENAMEX> (TNFα), or
          <ENAMEX TYPE="ORGANIZATION">fibronectin</ENAMEX> (FN). Cytoskeletal anchored <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> were
          <ENAMEX TYPE="PERSON">extracted</ENAMEX>, and analyzed (<ENAMEX TYPE="PERSON">Blot</ENAMEX>) with secondary antibodies
          (α-mouse <ENAMEX TYPE="SUBSTANCE">HRP</ENAMEX> plus α-rabbit <ENAMEX TYPE="ORGANIZATION">HRP</ENAMEX> plus α-goat HRP conjugated
          <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX>.)
          Click here for file
          To determine whether binding of mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> leads to integrin-mediated
          <ENAMEX TYPE="PERSON">signaling</ENAMEX>, we looked at the status of
          integrin-<NUMEX TYPE="CARDINAL">cytoskeleton</NUMEX>-associated <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> [ <NUMEX TYPE="CARDINAL">66 67</NUMEX> ] after
          incubation with mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> in selected carcinoma cell lines
          with different degrees of sensitivity to TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> (<ENAMEX TYPE="PRODUCT">Table 1</ENAMEX>). Cytoskeletal anchored
          <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> were precipitated with anti α 
          <ENAMEX TYPE="PERSON">V</ENAMEX> and β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> -antibodies. Immobilization of
          <ENAMEX TYPE="ORGANIZATION">proteins</ENAMEX> to the cytoskeleton (<ENAMEX TYPE="LAW">Triton-X</ENAMEX> insoluble
          fraction, Figure <NUMEX TYPE="CARDINAL">2B</NUMEX>) as well as tyrosine phosphorylation
          of these <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> (Figure <NUMEX TYPE="CARDINAL">2A</NUMEX>) induced through mature TGFβ
          
          <NUMEX TYPE="CARDINAL">1</NUMEX> was only seen in the TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> -sensitive carcinoma cell lines
          (Figure <NUMEX TYPE="CARDINAL">2and</NUMEX> additional file <NUMEX TYPE="CARDINAL">5</NUMEX>). Notably, tyrosine
          phosphorylation of <ENAMEX TYPE="SUBSTANCE">cytoskeletally anchored proteins</ENAMEX> is
          further enhanced after combined treatment with mature
          TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> and fibronectin in TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> sensitive <ENAMEX TYPE="SUBSTANCE">cells</ENAMEX> (Figure <NUMEX TYPE="CARDINAL">3</NUMEX>). In
          contrast, in the TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> -resistant <ENAMEX TYPE="PRODUCT">AsPC-1</ENAMEX> and <ENAMEX TYPE="GPE">Capan</ENAMEX>-<NUMEX TYPE="CARDINAL">1</NUMEX> cells,
          the interaction of mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> with α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> <ENAMEX TYPE="FAC_DESC">integrin</ENAMEX> resulted in an
          immobilization of high molecular weight <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> to the
          <ENAMEX TYPE="ORGANIZATION">cytoskeleton</ENAMEX> without tyrosine phosphorylation (Figure <NUMEX TYPE="CARDINAL">2</NUMEX>).
          Again, stimulation of TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> sensitive <ENAMEX TYPE="SUBSTANCE">cells</ENAMEX> <ENAMEX TYPE="PRODUCT">BxPC-3</ENAMEX>, <ENAMEX TYPE="GPE">LoVo</ENAMEX> [ <TIMEX TYPE="DATE">68</TIMEX> ]
          , SW48 [ <TIMEX TYPE="DATE">68</TIMEX> ] , <ENAMEX TYPE="ORGANIZATION">Keratinocytes, HeLa</ENAMEX> and <ENAMEX TYPE="PRODUCT">DLD1</ENAMEX> [ <TIMEX TYPE="DATE">69</TIMEX> ] ,
          results in an enhanced cytoskeletal immobilization and
          tyrosine phosphorylation of cellular <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> in response
          to stimulation with mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> (additional file <NUMEX TYPE="CARDINAL">5</NUMEX>). <ENAMEX TYPE="CONTACT_INFO">Remarkably,</ENAMEX>
          preincubation with the <ENAMEX TYPE="PRODUCT">MEK1</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">inhibitor</ENAMEX> <ENAMEX TYPE="PRODUCT">PD98059</ENAMEX> resulted in
          a reduced cytoskeletal immobilization and tyrosine
          phosphorylation of cellular <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> in response to
          stimulation with mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> . This finding is in agreement with
          other observations that <NUMEX TYPE="CARDINAL">MEK1</NUMEX>-mediated signal transduction
          is involved in cytoskeletal remodeling and integrin
          engagement [ <NUMEX TYPE="CARDINAL">70 71</NUMEX> ] .
          Additional File 5
          <ENAMEX TYPE="ORGANIZATION">Portable Network Graphic</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">PNG</ENAMEX>) File showing enhanced
          cytoskeletal immobilization and tyrosine phosphorylation
          of cellular <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> in response to stimulation with
          mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> . Cytoskeletally anchored α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> was immunoprecipitated after TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> stimulation (<NUMEX TYPE="CARDINAL">10</NUMEX> nM for <TIMEX TYPE="TIME">10 minutes</TIMEX>)
          followed by <ENAMEX TYPE="NATIONALITY">Western</ENAMEX> analysis with <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> against
          tyrosine-phosphorylated <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> (A) or Western blotting
          after biotinylation of all <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> and streptavidin
          <ENAMEX TYPE="ORGANIZATION">detection</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">B</ENAMEX>). In part the cells were preincubated with α
          
          <ENAMEX TYPE="PRODUCT">V -</ENAMEX> and β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> -<ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">1:100</ENAMEX> each for <TIMEX TYPE="TIME">30 min</TIMEX>)
          or with a TGFβ-RII <ENAMEX TYPE="SUBSTANCE">antibody</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">15 μg/ml</ENAMEX> for <TIMEX TYPE="TIME">30 min</TIMEX>).
          Click here for file
          Activation of p125 <ENAMEX TYPE="ORGANIZATION">FAK</ENAMEX>, a central step in
          integrin-associated signaling [ <NUMEX TYPE="CARDINAL">72 73</NUMEX> ] , was determined
          to assess integrin-mediated signaling. BcPC-<NUMEX TYPE="CARDINAL">3</NUMEX> cells are
          sensitive to TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> but are SMAD4 deleted. We incubated
          BxPC-<NUMEX TYPE="CARDINAL">3</NUMEX> cells with mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> and observed an association on the
          <ENAMEX TYPE="PERSON">cytoskeleton</ENAMEX> connected with integrin α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> and activation of p125 <ENAMEX TYPE="ORGANIZATION">FAK</ENAMEX>(Figure
          <NUMEX TYPE="CARDINAL">4</NUMEX>). Indeed, TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX>, cytochalasin <ENAMEX TYPE="NATIONALITY">D</ENAMEX> and
          BAPTA-AM [ <TIMEX TYPE="DATE">66</TIMEX> ] abolished the <ENAMEX TYPE="ORG_DESC">association</ENAMEX> on the
          <ENAMEX TYPE="PERSON">cytoskeleton</ENAMEX> connected with integrin α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> and activation of p125 <ENAMEX TYPE="ORGANIZATION">FAK</ENAMEX>. These
          <ENAMEX TYPE="ORGANIZATION">data</ENAMEX> further suggest that TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> mediated activation of p125
          <ENAMEX TYPE="ORGANIZATION">FAKdepends</ENAMEX> on free intracellular calcium and an intact
          actin cytoskeleton.
          In order to test whether TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> signaling via α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <ENAMEX TYPE="PRODUCT">6</ENAMEX> is specific for <TIMEX TYPE="DATE">SMAD4</TIMEX> deleted BxPC-3
          cells or if this is a general phenomenon, we investigated
          signaling in TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> -sensitive carcinoma cell lines
          HeLa, <ENAMEX TYPE="SUBSTANCE">MCF-7</ENAMEX> and <ENAMEX TYPE="PRODUCT">MDA-MB-231</ENAMEX>. TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> induced recruitment of p125 <ENAMEX TYPE="ORGANIZATION">Fak</ENAMEX>,
          p130 <ENAMEX TYPE="ORGANIZATION">Casand</ENAMEX> <NUMEX TYPE="CARDINAL">Sos1/2</NUMEX> to the cytoskeleton. Enhanced
          expression of c-jun, c-fos, <ENAMEX TYPE="PRODUCT">p21 WAF1and p27 KIP</ENAMEX>, while
          <ENAMEX TYPE="ORGANIZATION">downregulating PCNA</ENAMEX>, is dependent on <NUMEX TYPE="CARDINAL">ERK1/2</NUMEX> signaling, an
          intact cytoskeleton and intracellular calcium (Figures <NUMEX TYPE="CARDINAL">5</NUMEX>,
          6A, <NUMEX TYPE="CARDINAL">7</NUMEX>, <NUMEX TYPE="CARDINAL">8and</NUMEX> additional files <ENAMEX TYPE="CONTACT_INFO">6, 7and 8</ENAMEX>). We also
          confirmed the purity of the commercially available mature
          TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> used in these experiments by silver
          stained non-reducing <ENAMEX TYPE="ORGANIZATION">SDS</ENAMEX>-PAGE, with latent TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> as control (Figure <NUMEX TYPE="CARDINAL">6B</NUMEX>). We also
          demonstrated <TIMEX TYPE="DATE">the SMAD4</TIMEX> deficiency of the <ENAMEX TYPE="GPE">BxPC</ENAMEX>-<NUMEX TYPE="CARDINAL">3</NUMEX> cells
          used (Figure <NUMEX TYPE="CARDINAL">6C</NUMEX>).
          Additional File 6
          <ENAMEX TYPE="ORGANIZATION">Portable Network Graphic</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">PNG</ENAMEX>) File showing cell cycle
          genes in response to TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> . Western <ENAMEX TYPE="PERSON">Blot</ENAMEX> analysis of <ENAMEX TYPE="ORGANIZATION">HeLa</ENAMEX>,
          <ENAMEX TYPE="SUBSTANCE">MCF-7</ENAMEX> and <ENAMEX TYPE="PERSON">Keratinocytes</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">Keratino</ENAMEX>) cells as indicated
          after stimulation with TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> for the time indicated.
          Cytoskeletally anchored <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> are differentially
          marked. In part the cells were preincubated with α 
          <ENAMEX TYPE="PRODUCT">V -</ENAMEX> and β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> -<ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">1:100</ENAMEX> each for <TIMEX TYPE="TIME">30 min</TIMEX>),
          with a TGFβ-RII <ENAMEX TYPE="SUBSTANCE">antibody</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">15 μg/ml</ENAMEX> for <TIMEX TYPE="TIME">30 min</TIMEX>),
          <TIMEX TYPE="DATE">cytochalasin</TIMEX> D, <ENAMEX TYPE="ORGANIZATION">BAPTA AM</ENAMEX> and <ENAMEX TYPE="PRODUCT">MEK1</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">inhibitor</ENAMEX> <ENAMEX TYPE="PRODUCT">PD98059</ENAMEX>,
          respectively.
          Click here for file
          Additional File 7
          <ENAMEX TYPE="ORGANIZATION">Portable Network Graphic</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">PNG</ENAMEX>) File showing that PCNA
          regulation is dependent on α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> integrins, intact cytoskeleton and
          free intracellular calcium. BxPC-<NUMEX TYPE="CARDINAL">3</NUMEX> cells were stimulated
          with <NUMEX TYPE="CARDINAL">10</NUMEX> nM of mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> for <TIMEX TYPE="TIME">6 hours</TIMEX>. In part the cells were
          preincubated with α 
          <ENAMEX TYPE="PRODUCT">V -</ENAMEX> and β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> -<ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">1:100</ENAMEX> each for <TIMEX TYPE="TIME">30 min</TIMEX>),
          with a <ENAMEX TYPE="SUBSTANCE">TGFβ antibody</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">15 μg/ml</ENAMEX> for <TIMEX TYPE="TIME">30 min</TIMEX>), cytochalasin
          D and <ENAMEX TYPE="ORGANIZATION">BAPTA AM</ENAMEX>, respectively. Whole cell extract was
          probed with <ENAMEX TYPE="SUBSTANCE">PCNA antibodies</ENAMEX>. <ENAMEX TYPE="PERSON">Actin</ENAMEX> served as loading
          <ENAMEX TYPE="ORGANIZATION">control</ENAMEX>.
          Click here for file
          Additional File 8
          <ENAMEX TYPE="ORGANIZATION">Portable Network Graphic</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">PNG</ENAMEX>) File showing tha
          regulation of <TIMEX TYPE="DATE">p27</TIMEX>, <TIMEX TYPE="DATE">p21</TIMEX>, c-fos and c-jun are dependent on
          α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> integrins, intact cytoskeleton and
          free intracellular calcium. BxPC-<NUMEX TYPE="CARDINAL">3</NUMEX> cells were stimulated
          with <NUMEX TYPE="CARDINAL">10</NUMEX> nM of mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> for <TIMEX TYPE="TIME">6 hours</TIMEX>. In part the cells were
          preincubated with α 
          <ENAMEX TYPE="PRODUCT">V -</ENAMEX> and β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> -<ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">1:100</ENAMEX> each for <TIMEX TYPE="TIME">30 min</TIMEX>),
          with a TGFβ-RII <ENAMEX TYPE="SUBSTANCE">antibody</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">15 μg/ml</ENAMEX> for <TIMEX TYPE="TIME">30 min</TIMEX>),
          cytochalasin <ENAMEX TYPE="NATIONALITY">D</ENAMEX> and <ENAMEX TYPE="ORGANIZATION">BAPTA AM</ENAMEX>, respectively. Whole cell
          extract was probed with <ENAMEX TYPE="SUBSTANCE">PCNA antibodies</ENAMEX>. <ENAMEX TYPE="PERSON">Actin</ENAMEX> served as
          loading control.
          Click here for file
        
        
          <ENAMEX TYPE="ORGANIZATION">TGFβ</ENAMEX> <ENAMEX TYPE="PRODUCT">1/α Vβ 6integrin</ENAMEX> signaling is independent of
          the known <ENAMEX TYPE="ORGANIZATION">TGFβ</ENAMEX> <ENAMEX TYPE="PRODUCT">1signaling</ENAMEX> pathway
          To explain the TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> sensitivity of <NUMEX TYPE="CARDINAL">SMAD4</NUMEX>-deleted cells,
          it is speculated that after binding of TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> to its <ENAMEX TYPE="SUBSTANCE">receptor</ENAMEX>, activated <NUMEX TYPE="CARDINAL">SMAD2/3</NUMEX>
          may translocate to the nucleus and activate gene
          expression even in the absence of <TIMEX TYPE="DATE">SMAD4</TIMEX>. To exclude this
          possibility, cellular <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> were divided into
          <ENAMEX TYPE="ORGANIZATION">cytoplasmatic</ENAMEX> and nuclear fractions after TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> stimulation, and localization and
          phosphorylation of <NUMEX TYPE="CARDINAL">SMAD2/3</NUMEX> were investigated. In the
          SMAD4 deleted BxPC-<NUMEX TYPE="CARDINAL">3</NUMEX> cells, TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> resulted in phosphorylation of
          SMAD2<NUMEX TYPE="CARDINAL">/3</NUMEX>, but the activated <ENAMEX TYPE="SUBSTANCE">SMAD proteins</ENAMEX> were retained in
          the cytoplasmatic fraction (Figure <NUMEX TYPE="CARDINAL">9</NUMEX>). <ENAMEX TYPE="PERSON">Remarkably</ENAMEX>, in
          <ENAMEX TYPE="ORGANIZATION">NP</ENAMEX>-<NUMEX TYPE="CARDINAL">9</NUMEX> cells [ <TIMEX TYPE="DATE">74</TIMEX> ] , <NUMEX TYPE="CARDINAL">SMAD2/3</NUMEX> are translocated into the
          nucleus upon TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> stimulation (additional file 9(A))
          but we could not observe an enhanced tyrosine
          phosphorylation of cytoskeletal anchored proteins
          (additional file 9(<ENAMEX TYPE="ORGANIZATION">B</ENAMEX>)).
          Additional File 9
          <ENAMEX TYPE="ORGANIZATION">Portable Network Graphic</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">PNG</ENAMEX>) File showing activation
          and nuclear translocation of <NUMEX TYPE="CARDINAL">SMAD2/3</NUMEX> in response to TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> (A). Nuclear and cytoplasmatic
          fraction of cellular <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> (<NUMEX TYPE="MONEY">NP9</NUMEX>) after stimulation
          with <NUMEX TYPE="CARDINAL">10</NUMEX> nM of TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> for <TIMEX TYPE="TIME">10 minutes</TIMEX> and Western blot
          analysis for <NUMEX TYPE="CARDINAL">SMAD2/3</NUMEX> and phosphorylated <NUMEX TYPE="CARDINAL">SMAD2/3</NUMEX>.
          Cytoskeletally anchored α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> was immunoprecipitated after TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> stimulation (<NUMEX TYPE="CARDINAL">10</NUMEX> nM for <TIMEX TYPE="TIME">10 minutes</TIMEX>)
          followed by <ENAMEX TYPE="NATIONALITY">Western</ENAMEX> analysis with <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> against
          tyrosine-phosphorylated <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> (C) or Western blotting
          after biotinylation of all <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> and streptavidin
          <ENAMEX TYPE="ORGANIZATION">detection</ENAMEX> (<ENAMEX TYPE="NATIONALITY">D</ENAMEX>). In part the cells were preincubated with α
          
          <ENAMEX TYPE="PRODUCT">V -</ENAMEX> and β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> -<ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">1:100</ENAMEX> each for <TIMEX TYPE="TIME">30 min</TIMEX>)
          or with a <ENAMEX TYPE="SUBSTANCE">TGFβ antibody</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">15 μg/ml</ENAMEX> for <TIMEX TYPE="TIME">30 min</TIMEX>).
          Click here for file
        
        
          <ENAMEX TYPE="ORGANIZATION">TGFβ</ENAMEX> <ENAMEX TYPE="PRODUCT">1mediated</ENAMEX> growth inhibition is dependent on α
          Vβ 6integrin
          Influence of TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> on cell growth is well established,
          but the mechanisms are not fully understood [ <NUMEX TYPE="CARDINAL">75 76 77 78</NUMEX>
          <NUMEX TYPE="CARDINAL">79</NUMEX> ] . Here, we assayed for the possible synergistic
          function of α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> integrin on mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> mediated growth inhibition in <ENAMEX TYPE="GPE">Panc</ENAMEX>-1
          cells. As shown in the additional file <TIMEX TYPE="DATE">10</TIMEX>, combined
          treatment with α 
          <ENAMEX TYPE="PERSON">V</ENAMEX> and β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> blocking antibodies almost
          completely abolished the effect of mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> on the growth of <ENAMEX TYPE="GPE">Panc</ENAMEX>-<NUMEX TYPE="CARDINAL">1</NUMEX> cells. We
          therefore postulate that the growth inhibition of TGFβ 
          <ENAMEX TYPE="PRODUCT">1</ENAMEX> is synergistically influenced by α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <TIMEX TYPE="TIME">6 integrin.</TIMEX>
          Additional File <NUMEX TYPE="CARDINAL">10</NUMEX>
          <ENAMEX TYPE="ORGANIZATION">Microsoft</ENAMEX> <ENAMEX TYPE="PRODUCT">Excel</ENAMEX> spreadsheet showing TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> elicited growth inhibition of <ENAMEX TYPE="GPE">Panc</ENAMEX>-1
          cells is dependent on α 
          <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> integrin function. The assay was
          performed as described in the "<ENAMEX TYPE="WORK_OF_ART">Methods</ENAMEX>" section.
          Click here for file
        
      
      
        Discussion
        A recent study demonstrated an interaction of latent
        TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> with α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin, which led to an activation
        of latent TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> [ <TIMEX TYPE="DATE">45</TIMEX> ] . Incubation of different tumor
        cells with mature TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> resulted in a direct binding of TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> to α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <TIMEX TYPE="TIME">6 integrin.</TIMEX> Certain <ENAMEX TYPE="DISEASE">integrins</ENAMEX> appear to
        be preferentially associated with specific growth factor
        <ENAMEX TYPE="SUBSTANCE">receptors</ENAMEX> [ <TIMEX TYPE="DATE">80</TIMEX> ] . The interaction of these <NUMEX TYPE="CARDINAL">two</NUMEX> receptor
        classes seems to take place via the actin cytoskeleton. We
        were able to exclude such signal pathway <ENAMEX TYPE="ORG_DESC">association</ENAMEX>, since
        in our cytoskeletal preparations, no TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -<ENAMEX TYPE="SUBSTANCE">receptors</ENAMEX> were detectable, indicating
        that mature TGFβ 
        <ENAMEX TYPE="PRODUCT">1</ENAMEX> is a ligand for α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> .
        It has been reported that activated <ENAMEX TYPE="SUBSTANCE">integrins</ENAMEX> are
        <ENAMEX TYPE="ORGANIZATION">associated</ENAMEX> with the cytoskeleton. Here, we show that
        binding of mature TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> to α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> <ENAMEX TYPE="FAC_DESC">integrin</ENAMEX> resulted in an <ENAMEX TYPE="ORG_DESC">association</ENAMEX> of
        the cytoskeleton (Figure <NUMEX TYPE="CARDINAL">10</NUMEX>). In a variety of
        integrin-mediated signaling pathways,
        tyrosinephosphorylation of <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> immobilized to the
        <ENAMEX TYPE="ORGANIZATION">cytoskeleton</ENAMEX> is enhanced [ <NUMEX TYPE="CARDINAL">66 67</NUMEX> ] . The same was true in
        our experimental settings only for the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -sensitive cells. This upregulation of
        tyrosine phosphorylation was inhibited by preincubation
        with a TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> neutralizing <ENAMEX TYPE="SUBSTANCE">antibody</ENAMEX> or by blocking
        of α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin, thus again proving mature
        TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> as an initial signaling ligand for α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> .
        Binding of mature TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> to α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin exerts several downstream
        effects in TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -sensitive <ENAMEX TYPE="SUBSTANCE">cells</ENAMEX> (Figure <NUMEX TYPE="CARDINAL">9</NUMEX>). One is a
        marked phosphorylation of p125 <ENAMEX TYPE="ORGANIZATION">FAK</ENAMEX>. This phosphorylation is
        dependent on the integrity of the cytoskeleton, as
        disruption of actin filaments by <TIMEX TYPE="DATE">cytochalasin</TIMEX> D completely
        eliminated this effect, findings which have also been
        reported for several integrin signaling pathways [ <NUMEX TYPE="CARDINAL">66 67</NUMEX> ]
        . Moreover, incubation of the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> sensitive carcinoma cells with TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> caused immobilization of the docking
        <ENAMEX TYPE="SUBSTANCE">protein p130</ENAMEX> casand of the guanine nucleotide exchange
        <ENAMEX TYPE="ORGANIZATION">factor SOS</ENAMEX> to the cytoskeleton. Beyond this, a marked
        induction of the cell cycle <ENAMEX TYPE="SUBSTANCE">inhibitors p21 WAF1and</ENAMEX> p27
        <ENAMEX TYPE="ORGANIZATION">KIPand</ENAMEX> a decrease in PCNA expression was detectable.
        Finally, TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> caused an activation of <ENAMEX TYPE="SUBSTANCE">p21Ras</ENAMEX> and the
        <ENAMEX TYPE="SUBSTANCE">MAP kinases ERK1</ENAMEX> and <TIMEX TYPE="DATE">ERK2</TIMEX>. This TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -induced expression profile was not
        affected by preincubation of <ENAMEX TYPE="PRODUCT">SMAD4 deleted BxPC-3</ENAMEX> cells
        with a TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -RII blocking <ENAMEX TYPE="SUBSTANCE">antibody</ENAMEX>, which was able
        to completely block TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -induced <NUMEX TYPE="CARDINAL">SMAD2/3</NUMEX> phosphorylation, thus
        demonstrating the independence of the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -signaling from the known SMAD pathway
        in <ENAMEX TYPE="GPE">BxPC</ENAMEX>-<NUMEX TYPE="CARDINAL">3</NUMEX> cells. In contrast, preincubation with α 
        <ENAMEX TYPE="PRODUCT">V -</ENAMEX> and β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> -blocking antibodies curbed the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -induced regulation of <ENAMEX TYPE="CONTACT_INFO">p21/WAF1, p27,</ENAMEX>
        c-fos, and <TIMEX TYPE="DATE">the p21Ras</TIMEX> and <NUMEX TYPE="CARDINAL">ERK1/2</NUMEX> activation, verifying that
        the binding of TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> to the α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin is a prerequisite for the
        activation of the signal pathway via the α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <TIMEX TYPE="TIME">6 integrin.</TIMEX> Preincubation of the cells
        with the <ENAMEX TYPE="PRODUCT">MEK1</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">inhibitor</ENAMEX> <ENAMEX TYPE="PRODUCT">PD98059</ENAMEX> curbed the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -induced regulation of these genes as
        well, indicating the involvement of the <ENAMEX TYPE="ORGANIZATION">MAP</ENAMEX> kinase pathway
        in TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> signaling in <ENAMEX TYPE="GPE">BxPC</ENAMEX>-<NUMEX TYPE="CARDINAL">3</NUMEX> cells. As shown
        recently, the growth-stimulatory effect of the TGFβ
        <ENAMEX TYPE="ORGANIZATION">superfamily</ENAMEX> member <ENAMEX TYPE="PRODUCT">BMP-2on CAPAN-1</ENAMEX> cells was blocked by
        this inhibitor as well [ <NUMEX TYPE="CARDINAL">81 82 83</NUMEX> ] , supporting our
        findings.
        Indeed, cytoskeletal immobilization of <ENAMEX TYPE="SUBSTANCE">p130cas</ENAMEX> and SOS
        was not prevented by <TIMEX TYPE="DATE">the MEK1</TIMEX> inhibitor <ENAMEX TYPE="LAW">PD 98059</ENAMEX>. Thus,
        these <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> are good <ENAMEX TYPE="PER_DESC">candidates</ENAMEX> to link the
        integrin-mediated TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> signaling to the <ENAMEX TYPE="DISEASE">MAP kinase pathway</ENAMEX>,
        as was shown previously for signaling events induced by
        <ENAMEX TYPE="DISEASE">fluid stress</ENAMEX> or integrin mediated <ENAMEX TYPE="FAC_DESC">cell</ENAMEX>-adhesion in other
        cell types [ <NUMEX TYPE="CARDINAL">71 84 85 86 87 88 89 90 91</NUMEX> ] .
        In order to generalize the integrin mediated TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -pathway identified in the SMAD4
        deleted pancreatic tumor cell line <ENAMEX TYPE="PRODUCT">BxPC-3</ENAMEX>, we investigated
        TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> signaling in the cervical carcinoma
        cell line <ENAMEX TYPE="PERSON">HeLa</ENAMEX> and the mammary carcinoma cell lines MCF-7
        and <ENAMEX TYPE="PRODUCT">MDA-MB-231</ENAMEX>, harboring a wildtype <NUMEX TYPE="CARDINAL">SMAD4</NUMEX>-gene. TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> bound to α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> -integrin in these <ENAMEX TYPE="FAC_DESC">cells</ENAMEX> as well, and
        this interaction resulted both in an immobilization of
        p130Cas and <NUMEX TYPE="CARDINAL">SOS1/2</NUMEX> and in tyrosine phosphorylation of
        cytoskeleton-associated <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> such as <TIMEX TYPE="DATE">p125FAK</TIMEX>. TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> stimulation of these cells acvtivated
        p21Ras and <ENAMEX TYPE="ORGANIZATION">MAPK</ENAMEX> <NUMEX TYPE="CARDINAL">ERK1/2</NUMEX>, upregulated c-fos, <ENAMEX TYPE="CONTACT_INFO">c-jun/AP1,</ENAMEX>
        <ENAMEX TYPE="CONTACT_INFO">p21/WAF1</ENAMEX> and <ENAMEX TYPE="PRODUCT">p27</ENAMEX> expression, and resulted a decrease of
        <ENAMEX TYPE="ORGANIZATION">PCNA</ENAMEX>, similar to its actions in <ENAMEX TYPE="GPE">BxPC</ENAMEX>-<NUMEX TYPE="CARDINAL">3</NUMEX> cells. Preincubation
        with a TGFβ-RII blocking <ENAMEX TYPE="SUBSTANCE">antibody</ENAMEX> attenuated the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> induced pattern, contrary to <ENAMEX TYPE="ORGANIZATION">SMAD</ENAMEX> 4
        <ENAMEX TYPE="PERSON">deleted BxPC</ENAMEX>-<NUMEX TYPE="CARDINAL">3</NUMEX> cells. This preincubation also decreased
        activation of <ENAMEX TYPE="SUBSTANCE">p21Ras</ENAMEX> and of <ENAMEX TYPE="ORGANIZATION">MAPK</ENAMEX> <NUMEX TYPE="CARDINAL">ERK1/2</NUMEX>, indicating the
        participation of the <ENAMEX TYPE="ORGANIZATION">Ras/MAPK</ENAMEX>-pathway in TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> induced transcriptional
        <ENAMEX TYPE="ORGANIZATION">activation</ENAMEX>.
        The same attenuation of TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> induced gene expression and the
        decrease in <TIMEX TYPE="DATE">p21Ras</TIMEX> and <ENAMEX TYPE="ORGANIZATION">MAPK</ENAMEX> <ENAMEX TYPE="PRODUCT">ERK1/2</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">activation</ENAMEX> was
        <ENAMEX TYPE="ORGANIZATION">observable</ENAMEX> after preincubation of <ENAMEX TYPE="PRODUCT">SMAD4</ENAMEX> wildtype cells with
        α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> -blocking antibodies, demonstrating
        that TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> signaling via α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> -integrin also is linked to the
        <ENAMEX TYPE="ORGANIZATION">Ras/MAPK</ENAMEX>-pathway, and that both <ENAMEX TYPE="PER_DESC">pathways</ENAMEX> have synergistic
        effects in TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -signaling. <TIMEX TYPE="DATE">Full</TIMEX> TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> induced transcriptional activation is
        only reached if both pathways are completed. This finding
        is supported by the observation that activation of <ENAMEX TYPE="CONTACT_INFO">p21/Ras</ENAMEX>
        and <ENAMEX TYPE="ORGANIZATION">MAPK</ENAMEX> <NUMEX TYPE="CARDINAL">ERK1/2</NUMEX> induced by TGFβ 
        <ENAMEX TYPE="PRODUCT">1</ENAMEX> is only reverted to the control level
        by the combination of the TGFβ-RII blocking <ENAMEX TYPE="SUBSTANCE">antibody</ENAMEX> and
        the α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> -blocking antibodies, or by inhibition
        of <TIMEX TYPE="DATE">MEK1</TIMEX>.
        Linking of the TGFβ-<ENAMEX TYPE="NATIONALITY">R</ENAMEX> pathway to the <ENAMEX TYPE="ORGANIZATION">Ras/MAPK</ENAMEX> pathway is
        dependent on a functional SMAD4 gene product, because TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> induced gene expression and activation
        of <ENAMEX TYPE="ORGANIZATION">Ras</ENAMEX> and <NUMEX TYPE="CARDINAL">ERK1/2</NUMEX> is attenuated by the TGFβ-RII blocking
        antibody only in <TIMEX TYPE="DATE">SMAD4</TIMEX> wild type cells, whereas in the
        SMAD4 deleted BxPC-<NUMEX TYPE="CARDINAL">3</NUMEX> cells, no such influence was
        <ENAMEX TYPE="ORGANIZATION">observable</ENAMEX>.
        Based on our results, we suggest the following model of
        TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -signaling, which offers an
        explanation for the different growth responses to TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> (<ENAMEX TYPE="PERSON">Fig</ENAMEX>. <NUMEX TYPE="CARDINAL">10</NUMEX>). In the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -sensitive cell lines with intact SMAD
        pathway, the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> response can be attributed to both the
        <ENAMEX TYPE="ORGANIZATION">common SMAD</ENAMEX> signaling pathway and the integrin pathway
        described above. In the cell line <ENAMEX TYPE="PRODUCT">BxPC-3</ENAMEX>, lacking the SMAD4
        gene product, <TIMEX TYPE="DATE">the SMAD4-independent</TIMEX> pathway can explain the
        TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> sensitivity via α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin, the cytoskeleton and the
        Ras/<ENAMEX TYPE="DISEASE">MAP kinase pathway</ENAMEX>, resulting in an upregulation of the
        cell cycle inhibitiors <ENAMEX TYPE="CONTACT_INFO">p21/WAF1</ENAMEX> and <ENAMEX TYPE="PRODUCT">p27</ENAMEX>, which in turn
        results in the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> -induced growth inhibition (additional
        file <NUMEX TYPE="CARDINAL">10</NUMEX>).
        The cell lines <ENAMEX TYPE="PRODUCT">Capan-1</ENAMEX> and <ENAMEX TYPE="PRODUCT">AsPC-1</ENAMEX> are not only resistant
        to TGFβ 
        <ENAMEX TYPE="PRODUCT">1</ENAMEX> because of their alterations in the
        <ENAMEX TYPE="ORGANIZATION">SMAD</ENAMEX> pathway, but also because they cannot complete the
        alternate pathway, as demonstrated above. Furthermore, this
        <ENAMEX TYPE="PER_DESC">alternate pathway</ENAMEX> may explain the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> <ENAMEX TYPE="ORG_DESC">resistance</ENAMEX> of cells with no detectable
        defect in the <ENAMEX TYPE="ORGANIZATION">SMAD</ENAMEX> <ENAMEX TYPE="PER_DESC">pathway</ENAMEX> [ <NUMEX TYPE="CARDINAL">92 93 94 95 96 97 98 99 100</NUMEX>
        <NUMEX TYPE="CARDINAL">101</NUMEX> ] , as one can imagine that the cooperative action of
        the both pathways is necessary to exert the complete growth
        inhibitory effect of TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> . Comparable effects have been
        described for the synergistic operation of growth factor
        <ENAMEX TYPE="SUBSTANCE">receptor</ENAMEX> and anchorage dependent integrin signaling [ <NUMEX TYPE="CARDINAL">102</NUMEX>
        <NUMEX TYPE="CARDINAL">103 104 105 106 107 108 109 110 111 112 113 114 115 116 117</NUMEX>
        <NUMEX TYPE="CARDINAL">118 119</NUMEX> ] .
        Recombinant mature TGFβ 
        <ENAMEX TYPE="PRODUCT">1</ENAMEX> does not contain a RGD motif, and thus
        binding of TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> to the α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin and the subsequent activation
        of this integrin must rely on a novel motif distinct from
        <ENAMEX TYPE="ORGANIZATION">RGD</ENAMEX>. For α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin, a novel non-RGD ligand
        <ENAMEX TYPE="ORGANIZATION">recognition</ENAMEX> motif was recently described with the consensus
        <ENAMEX TYPE="ORGANIZATION">motif DLXXL</ENAMEX> [ <ENAMEX TYPE="LAW">120</ENAMEX> ] .
        This motif has been detected on several <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX>,
        including laminin, collagen and fibrinogen [ <ENAMEX TYPE="LAW">120</ENAMEX> ] . A
        BLAST search for this sequence in TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> revealed a <NUMEX TYPE="PERCENT">70%</NUMEX> similar motif in two
        parts of the molecule; one in the <ENAMEX TYPE="ORGANIZATION">LAP</ENAMEX> (data not shown) and
        <NUMEX TYPE="CARDINAL">one</NUMEX> in the mature TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> . In mature TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> , the DLXXL motif is freely accessible
        for interactions on the outside of the molecule. Therefore,
        it may be speculated that TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> binding to α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> via this novel ligand recognition
        <ENAMEX TYPE="PERSON">motif</ENAMEX> is facilitating the signaling. Moreover, a non-RGD
        ligand binding pocket in addition to the usual <ENAMEX TYPE="ORGANIZATION">RGD</ENAMEX> binding
        site has been demonstrated for fibrinogen and the α 
        <ENAMEX TYPE="ORGANIZATION">IIb</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">3</NUMEX> <ENAMEX TYPE="PER_DESC">integrin</ENAMEX> [ <ENAMEX TYPE="LAW">121</ENAMEX> ] , supporting our
        findings.
      
      
        Conclusions
        We demonstrate an alternate TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> signaling pathway via α 
        <ENAMEX TYPE="PRODUCT">V</ENAMEX> β 
        <NUMEX TYPE="CARDINAL">6</NUMEX> integrin, independent of <TIMEX TYPE="DATE">SMAD4</TIMEX>. This
        <ENAMEX TYPE="ORGANIZATION">pathway</ENAMEX> seems to be required for full TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> induced transcriptional activation,
        which explains the TGFβ 
        <NUMEX TYPE="CARDINAL">1</NUMEX> sensitivity of those cells lacking
        <ENAMEX TYPE="CONTACT_INFO">DPC4/SMAD4</ENAMEX> function that still react with growth
        <ENAMEX TYPE="ORGANIZATION">inhibition</ENAMEX>.
      
      
        Methods
        
          <ENAMEX TYPE="ORGANIZATION">Cell Culture and TGFβ</ENAMEX> 1stimulation
          All cells were obtained from from <ENAMEX TYPE="ORGANIZATION">ATCC</ENAMEX> and maintained
          in <ENAMEX TYPE="ORGANIZATION">DMEM</ENAMEX> supplemented with <NUMEX TYPE="PERCENT">17%</NUMEX> fetal calf serum.
          Recombinant human <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX> (mature TGFβ 
          <ENAMEX TYPE="LAW">1 , TNF-α, Fibronectin and Laminin 1</ENAMEX>)
          were purchased from <ENAMEX TYPE="ORGANIZATION">R&D Systems</ENAMEX>. <TIMEX TYPE="DATE">10 6cells</TIMEX> were grown
          overnight in <NUMEX TYPE="CARDINAL">6</NUMEX> cm diameter dishes with DMEM<NUMEX TYPE="PERCENT">/10 %</NUMEX> <ENAMEX TYPE="ORGANIZATION">FCS</ENAMEX>.
          After washing twice with <ENAMEX TYPE="ORGANIZATION">PBS</ENAMEX> (pH <NUMEX TYPE="CARDINAL">7.4</NUMEX>), fresh <ENAMEX TYPE="SUBSTANCE">DMEM</ENAMEX> without
          <ENAMEX TYPE="ORGANIZATION">FCS</ENAMEX> was added to the monolayer. Cells were stimulated
          with <NUMEX TYPE="CARDINAL">10</NUMEX> nM of mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> or with fibronectin as described
          below. In blocking experiments, cells were preincubated
          with either a TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> -RII-blocking <ENAMEX TYPE="SUBSTANCE">antibody</ENAMEX> (R&D
          <ENAMEX TYPE="ORGANIZATION">Systems #</ENAMEX> <ENAMEX TYPE="PRODUCT">AF-241-NA</ENAMEX>, <NUMEX TYPE="QUANTITY">15 </NUMEX>g/ml for <TIMEX TYPE="TIME">30 min</TIMEX>), α 
          <ENAMEX TYPE="PERSON">V</ENAMEX> and β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> -blocking <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> (<ENAMEX TYPE="GPE">Santa Cruz</ENAMEX>,
          sc-<NUMEX TYPE="CARDINAL">6617 and sc</NUMEX>-<TIMEX TYPE="DATE">6632</TIMEX> respectively, <TIMEX TYPE="TIME">1:100</TIMEX> each for <TIMEX TYPE="TIME">30 min</TIMEX>),
          or the <ENAMEX TYPE="PRODUCT">MEK1</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">inhibitor</ENAMEX> PD98059 (<ENAMEX TYPE="ORGANIZATION">New England Biolabs #</ENAMEX>
          9900S, <NUMEX TYPE="CARDINAL">7.5</NUMEX> <ENAMEX TYPE="PER_DESC">ng</ENAMEX>/ml for <TIMEX TYPE="TIME">10 min</TIMEX>) before stimulation with
          mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> .
        
        
          Indirect immunofluorescence
          For indirect <ENAMEX TYPE="ORG_DESC">immunofluorescence</ENAMEX>, <NUMEX TYPE="CARDINAL">10</NUMEX> 4cells were
          cultured on <ENAMEX TYPE="SUBSTANCE">glass coverslips</ENAMEX>, stimulated with <NUMEX TYPE="CARDINAL">10</NUMEX> nM
          mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> for <TIMEX TYPE="TIME">10 minutes</TIMEX>, stained as described
          [ <NUMEX TYPE="CARDINAL">66 67</NUMEX> ] and viewed using a <ENAMEX TYPE="ORGANIZATION">Zeiss</ENAMEX> <ENAMEX TYPE="PRODUCT">LSM-510</ENAMEX> confocal
          microscope. <ENAMEX TYPE="SUBSTANCE">Antibodies</ENAMEX> used were: actin (<ENAMEX TYPE="CONTACT_INFO">sc-8432</ENAMEX>), TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> (<ENAMEX TYPE="CONTACT_INFO">sc-146</ENAMEX>), α 
          <ENAMEX TYPE="PERSON">V</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">sc-6617</ENAMEX>) and β 
          <NUMEX TYPE="CARDINAL">6</NUMEX> (<ENAMEX TYPE="CONTACT_INFO">sc-6632</ENAMEX>). The following
          fluorochrome-labeled <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> were used (<ENAMEX TYPE="ORGANIZATION">AlexaFluor</ENAMEX>,
          <ENAMEX TYPE="PERSON">Molecular Probes</ENAMEX>): goat anti-mouse <ENAMEX TYPE="PERSON">IgG</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">H+L</ENAMEX>) conjugate
          (<NUMEX TYPE="MONEY">#</NUMEX><ENAMEX TYPE="PRODUCT">A-11032</ENAMEX>; red), goat anti-rabbit <ENAMEX TYPE="PERSON">IgG</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">H+L</ENAMEX>) conjugate
          (<NUMEX TYPE="MONEY">#</NUMEX><ENAMEX TYPE="PRODUCT">A-11046</ENAMEX>; blue), and donkey <ENAMEX TYPE="NATIONALITY">anti-goat</ENAMEX> IgG (<ENAMEX TYPE="ORGANIZATION">H+L</ENAMEX>)
          <ENAMEX TYPE="ORGANIZATION">conjugate</ENAMEX> (<NUMEX TYPE="MONEY">#</NUMEX><ENAMEX TYPE="PRODUCT">A-11055</ENAMEX>; green).
        
        
          Preparation of <ENAMEX TYPE="SUBSTANCE">cytoplasmatic proteins</ENAMEX> and of
          nuclei
          Cellular <ENAMEX TYPE="ORG_DESC">fractionation</ENAMEX> was performed as described in
          earlier reports [ <NUMEX TYPE="CARDINAL">122 123 124 125</NUMEX> ] . Cells were scraped
          into <NUMEX TYPE="CARDINAL">100</NUMEX> μl of <ENAMEX TYPE="SUBSTANCE">ice</ENAMEX>-cold buffer A [<NUMEX TYPE="CARDINAL">10</NUMEX> <ENAMEX TYPE="PER_DESC">mM</ENAMEX> <ENAMEX TYPE="PERSON">Hepes</ENAMEX> (pH <NUMEX TYPE="CARDINAL">7.9</NUMEX>);
          <NUMEX TYPE="CARDINAL">1.5</NUMEX> mM MgCl 
          <NUMEX TYPE="CARDINAL">2</NUMEX> ; <NUMEX TYPE="CARDINAL">10</NUMEX> mM <ENAMEX TYPE="ORGANIZATION">KCl</ENAMEX>; <NUMEX TYPE="CARDINAL">0.5</NUMEX> mM <ENAMEX TYPE="ORGANIZATION">DTT</ENAMEX>; <NUMEX TYPE="PERCENT">0.05%</NUMEX>
          <ENAMEX TYPE="ORGANIZATION">NP-40</ENAMEX>]. Nuclei were pelleted in a microcentrifuge for <NUMEX TYPE="CARDINAL">10</NUMEX>
          sec. at <TIMEX TYPE="DATE">4°C</TIMEX> and <NUMEX TYPE="CARDINAL">15,000</NUMEX> <ENAMEX TYPE="PRODUCT">G. The</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">supernatant</ENAMEX> was used to
          analyze cytoplasmatic <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX>, nuclei were resuspended
          in <NUMEX TYPE="QUANTITY">60 μl</NUMEX> of <ENAMEX TYPE="SUBSTANCE">ice</ENAMEX> cold buffer B [<NUMEX TYPE="CARDINAL">20</NUMEX> <ENAMEX TYPE="PER_DESC">mM</ENAMEX> <ENAMEX TYPE="PERSON">Hepes</ENAMEX> (pH <NUMEX TYPE="CARDINAL">7.9</NUMEX>); <NUMEX TYPE="PERCENT">25%</NUMEX>
          (<ENAMEX TYPE="PRODUCT">v/v</ENAMEX>) glycerol; <NUMEX TYPE="CARDINAL">420</NUMEX> mM <ENAMEX TYPE="ORGANIZATION">KCl</ENAMEX>; <NUMEX TYPE="CARDINAL">1.5</NUMEX> mM MgCl 
          <NUMEX TYPE="CARDINAL">2</NUMEX> ; <NUMEX TYPE="CARDINAL">0.2</NUMEX> mM <ENAMEX TYPE="ORGANIZATION">EDTA</ENAMEX>; <NUMEX TYPE="CARDINAL">0.5</NUMEX> mM <ENAMEX TYPE="ORGANIZATION">DTT</ENAMEX>; <NUMEX TYPE="CARDINAL">0.5</NUMEX> mM
          <ENAMEX TYPE="ORGANIZATION">PMSF</ENAMEX>] and incubated on <ENAMEX TYPE="SUBSTANCE">ice</ENAMEX> for <NUMEX TYPE="CARDINAL">15</NUMEX> min.
        
        
          Preparation of actin filaments of the cytoskeleton
          and immunoprecipitation
          The <ENAMEX TYPE="FAC_DESC">cell monolayer</ENAMEX> was incubated with cell extraction
          buffer [<NUMEX TYPE="PERCENT">0.1 %</NUMEX> <ENAMEX TYPE="ORGANIZATION">Triton X-100</ENAMEX>, <NUMEX TYPE="CARDINAL">80</NUMEX> mM <ENAMEX TYPE="ORGANIZATION">KCl</ENAMEX>, <NUMEX TYPE="CARDINAL">20</NUMEX> mM imidazole, <NUMEX TYPE="CARDINAL">2</NUMEX>
          mM MgCl 
          <NUMEX TYPE="CARDINAL">2</NUMEX> , <NUMEX TYPE="CARDINAL">2</NUMEX> mM <ENAMEX TYPE="ORGANIZATION">EGTA</ENAMEX>, pH <NUMEX TYPE="CARDINAL">7.8</NUMEX>] for <TIMEX TYPE="TIME">5 min</TIMEX> at
          4°C. The <ENAMEX TYPE="ORGANIZATION">Triton</ENAMEX>-insoluble fractions were then scraped
          into cold <ENAMEX TYPE="LAW">Triton X-100</ENAMEX> lysis buffer [<NUMEX TYPE="CARDINAL">50</NUMEX> mM <ENAMEX TYPE="ORGANIZATION">Tris/HCl</ENAMEX> (pH
          <NUMEX TYPE="MONEY">7.4</NUMEX>); <ENAMEX TYPE="PRODUCT">100</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">mM</ENAMEX> <ENAMEX TYPE="PRODUCT">NaCl; 50</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">mM</ENAMEX> <ENAMEX TYPE="PRODUCT">NaF; 5</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">mM EDTA</ENAMEX>; <NUMEX TYPE="CARDINAL">40</NUMEX> mM
          <ENAMEX TYPE="ORGANIZATION">glycerophosphate</ENAMEX>; <NUMEX TYPE="CARDINAL">1</NUMEX> mM sodium <ENAMEX TYPE="SUBSTANCE">orthovanadate</ENAMEX>; <ENAMEX TYPE="PRODUCT">100 μM PMSF</ENAMEX>;
          <NUMEX TYPE="CARDINAL">1</NUMEX> μM leupeptin; <NUMEX TYPE="CARDINAL">1</NUMEX> μM pepstatin A; <NUMEX TYPE="PERCENT">1%</NUMEX> (<ENAMEX TYPE="PRODUCT">v/v</ENAMEX>) <ENAMEX TYPE="LAW">Triton X-100</ENAMEX>]
          and incubated for <TIMEX TYPE="TIME">20 min</TIMEX> on <ENAMEX TYPE="SUBSTANCE">ice</ENAMEX>, and clarified by
          centrifugation at <NUMEX TYPE="CARDINAL">13000</NUMEX> g for <TIMEX TYPE="TIME">5 min</TIMEX> at <TIMEX TYPE="DATE">4°C</TIMEX>. For
          immunoprecipitation, the lysates were incubated for <NUMEX TYPE="CARDINAL">4</NUMEX> h
          at <NUMEX TYPE="ORDINAL">4°C</NUMEX> with <NUMEX TYPE="QUANTITY">1 μg</NUMEX> of <ENAMEX TYPE="SUBSTANCE">antibody</ENAMEX> (all from <ENAMEX TYPE="GPE">Santa Cruz</ENAMEX>)
          pre-adsorbed on <ENAMEX TYPE="SUBSTANCE">Protein A-Sepharose beads</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">Pharmacia</ENAMEX>).
          <ENAMEX TYPE="ORGANIZATION">Immune</ENAMEX> <ENAMEX TYPE="FAC_DESC">complexes</ENAMEX> were washed <NUMEX TYPE="CARDINAL">five</NUMEX> times with cold <ENAMEX TYPE="ORGANIZATION">Triton</ENAMEX>
          X-<NUMEX TYPE="CARDINAL">100 lysis</NUMEX> buffer. For re-precipitation, the pellet was
          <ENAMEX TYPE="ORGANIZATION">boiled</ENAMEX> in <TIMEX TYPE="DATE">10 </TIMEX>l <NUMEX TYPE="PERCENT">0.1%</NUMEX> <ENAMEX TYPE="ORGANIZATION">SDS</ENAMEX> for <TIMEX TYPE="TIME">5 min and diluted 1:20</TIMEX> in
          the <ENAMEX TYPE="LAW">Triton X</ENAMEX> lysis buffer followed by the precipitation
          procedure. All <ENAMEX TYPE="SUBSTANCE">samples</ENAMEX> were boiled in <ENAMEX TYPE="GPE">Laemmli</ENAMEX> denaturing
          buffer and analyzed by Western blotting. Whole cell
          <ENAMEX TYPE="ORG_DESC">lysates</ENAMEX> serving as positive controls were prepared by
          incubating monolayers with denaturing <ENAMEX TYPE="ORGANIZATION">Laemmli</ENAMEX> buffer.
        
        
          Treatment with <ENAMEX TYPE="ORGANIZATION">Cytochalasin and Calcium</ENAMEX>
          Chelator
          To disrupt the actin filaments of the cytoskeleton,
          the <ENAMEX TYPE="FAC_DESC">cell monolayer</ENAMEX> was treated with <NUMEX TYPE="CARDINAL">25</NUMEX> nM cytochalasin D
          for <TIMEX TYPE="TIME">20 min</TIMEX> at <TIMEX TYPE="DATE">37°C</TIMEX>; TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> was then applied in the presence of
          <NUMEX TYPE="CARDINAL">25</NUMEX> nM cytochalasin <ENAMEX TYPE="NATIONALITY">D.</ENAMEX> For chelating intracellular
          <ENAMEX TYPE="PERSON">calcium</ENAMEX>, the cells were preincubated with <NUMEX TYPE="QUANTITY">5 μM</NUMEX> of
          1,2-bis(<ENAMEX TYPE="CONTACT_INFO">2-aminophenoxy</ENAMEX>)ethane- 
          <ENAMEX TYPE="ORGANIZATION">N</ENAMEX> , 
          <ENAMEX TYPE="ORGANIZATION">N</ENAMEX> , 
          <ENAMEX TYPE="ORGANIZATION">N '</ENAMEX>, 
          <ENAMEX TYPE="ORGANIZATION">N</ENAMEX> '-tetraacetic <ENAMEX TYPE="SUBSTANCE">acid</ENAMEX>, acetoxymethyl
          <ENAMEX TYPE="ORGANIZATION">ester</ENAMEX> (BAPTA-<ENAMEX TYPE="ORGANIZATION">AM</ENAMEX>) for <NUMEX TYPE="CARDINAL">15</NUMEX> min. TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> was then applied in the presence of
          <NUMEX TYPE="QUANTITY">5 μM</NUMEX> of <ENAMEX TYPE="ORGANIZATION">BAPTA</ENAMEX>.
        
        
          [ 3H]-thymidine incorporation assay
          For the TGFβeta 
          <NUMEX TYPE="CARDINAL">1</NUMEX> growth inhibition assay, cells were
          seeded in <NUMEX TYPE="CARDINAL">96</NUMEX>-well microtitier plates at <NUMEX TYPE="CARDINAL">10</NUMEX> 4cells/well in
          <NUMEX TYPE="QUANTITY">100 μl</NUMEX> of culture medium containing <NUMEX TYPE="PERCENT">10%</NUMEX> <ENAMEX TYPE="ORGANIZATION">FCS</ENAMEX>. After <TIMEX TYPE="TIME">24 h</TIMEX>,
          medium was replaced by culture medium supplemented with
          <NUMEX TYPE="PERCENT">0.5%</NUMEX> <ENAMEX TYPE="ORGANIZATION">FCS</ENAMEX>. After <TIMEX TYPE="TIME">an additional 24 h</TIMEX>, cells were treated
          with <NUMEX TYPE="CARDINAL">10</NUMEX> nM of mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> . After incubation with TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> for <TIMEX TYPE="TIME">21 h</TIMEX>, cells were pulsed with <NUMEX TYPE="CARDINAL">200</NUMEX>
          <ENAMEX TYPE="ORGANIZATION">nCi</ENAMEX> of [ <TIMEX TYPE="DATE">3H</TIMEX>]-thymidine (<NUMEX TYPE="CARDINAL">1.74</NUMEX> <ENAMEX TYPE="ORGANIZATION">TBq/mmol; Amersham</ENAMEX>, <ENAMEX TYPE="GPE">UK</ENAMEX>) for
          <TIMEX TYPE="TIME">3 h</TIMEX> without changing the medium. Cells were washed once
          with <ENAMEX TYPE="ORGANIZATION">PBS</ENAMEX>, incubated with trypsin for <TIMEX TYPE="TIME">10 min</TIMEX> and collected
          by using a <ENAMEX TYPE="GPE">Skatron</ENAMEX> <ENAMEX TYPE="FAC_DESC">cell harvester</ENAMEX>. Radioactivity
          incorporated was determined by liquid scintillation
          counting.
        
        
          <ENAMEX TYPE="ORGANIZATION">Western Blot</ENAMEX>
          <ENAMEX TYPE="SUBSTANCE">Proteins</ENAMEX> were separated by <ENAMEX TYPE="ORGANIZATION">SDS</ENAMEX>-PAGE and transferred to
          a polyvinylidene difluoride membrane (<ENAMEX TYPE="ORGANIZATION">Roche</ENAMEX>) as described
          previously [ <TIMEX TYPE="DATE">66</TIMEX> ] . Blot membranes were blocked for <NUMEX TYPE="CARDINAL">3</NUMEX> h
          at <NUMEX TYPE="ORDINAL">37°C</NUMEX> in <ENAMEX TYPE="ORGANIZATION">PBS</ENAMEX> containing <NUMEX TYPE="PERCENT">5 %</NUMEX> skim <ENAMEX TYPE="SUBSTANCE">milk</ENAMEX> and probed with
          the respective <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> (<NUMEX TYPE="CARDINAL">16</NUMEX> h at <NUMEX TYPE="MONEY">4°C</NUMEX>). The following
          <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> were used in a dilution of <NUMEX TYPE="CARDINAL">1</NUMEX>:<NUMEX TYPE="CARDINAL">1,000</NUMEX>: TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> (<ENAMEX TYPE="GPE">Santa Cruz</ENAMEX> [<ENAMEX TYPE="SUBSTANCE">sc</ENAMEX>], sc-<NUMEX TYPE="CARDINAL">146</NUMEX>), <ENAMEX TYPE="PRODUCT_DESC">p</ENAMEX>-Tyr
          (<ENAMEX TYPE="CONTACT_INFO">sc-7020</ENAMEX>), β 
          <TIMEX TYPE="TIME">6 -integrin</TIMEX> (<ENAMEX TYPE="CONTACT_INFO">sc-6632</ENAMEX>), α 
          <ENAMEX TYPE="PERSON">V -integrin</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">sc-6617</ENAMEX>), p125
          <ENAMEX TYPE="ORGANIZATION">FAK</ENAMEX>(<ENAMEX TYPE="CONTACT_INFO">sc-557</ENAMEX>), TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> -RI (<ENAMEX TYPE="CONTACT_INFO">sc-402</ENAMEX>), TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> -RII (sc-<NUMEX TYPE="CARDINAL">400</NUMEX>-<ENAMEX TYPE="ORGANIZATION">G</ENAMEX>), <NUMEX TYPE="CARDINAL">ERK1/2</NUMEX>-P (<ENAMEX TYPE="CONTACT_INFO">sc-7383</ENAMEX>),
          SMAD2<NUMEX TYPE="CARDINAL">/3</NUMEX> (<ENAMEX TYPE="CONTACT_INFO">sc-6033</ENAMEX>), <NUMEX TYPE="CARDINAL">SOS1/2</NUMEX> (<ENAMEX TYPE="CONTACT_INFO">sc-259</ENAMEX>), <ENAMEX TYPE="PRODUCT">p130</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">cas</ENAMEX>(UBI-<NUMEX TYPE="CARDINAL">06-500</NUMEX>),
          <ENAMEX TYPE="ORGANIZATION">PCNA</ENAMEX> (sc-<NUMEX TYPE="CARDINAL">56</NUMEX>), <ENAMEX TYPE="PRODUCT">p21</ENAMEX> WAF1(<ENAMEX TYPE="CONTACT_INFO">sc-6246</ENAMEX>), <ENAMEX TYPE="PRODUCT">p27 KIP</ENAMEX>(<ENAMEX TYPE="CONTACT_INFO">sc-1641</ENAMEX>), c-fos
          (<ENAMEX TYPE="CONTACT_INFO">sc-7202</ENAMEX>), c-jun (sc-<NUMEX TYPE="CARDINAL">44</NUMEX>), <TIMEX TYPE="DATE">raf1</TIMEX> (<ENAMEX TYPE="CONTACT_INFO">sc-133</ENAMEX>), <ENAMEX TYPE="ORGANIZATION">p21 Ras</ENAMEX>(sc-<NUMEX TYPE="CARDINAL">35</NUMEX>)
          and phospho-threonine <ENAMEX TYPE="SUBSTANCE">antibody</ENAMEX> (<ENAMEX TYPE="ORGANIZATION">New England Biolabs</ENAMEX>, <NUMEX TYPE="MONEY">#</NUMEX>
          <TIMEX TYPE="DATE">9381</TIMEX>). Detection <ENAMEX TYPE="SUBSTANCE">antibodies</ENAMEX> (all from <ENAMEX TYPE="GPE">Dako</ENAMEX>; <NUMEX TYPE="CARDINAL">1</NUMEX>:<NUMEX TYPE="CARDINAL">5,000</NUMEX> for <NUMEX TYPE="CARDINAL">1</NUMEX>
          <ENAMEX TYPE="ORGANIZATION">h</ENAMEX> at room temperature) were mouse-<ENAMEX TYPE="NATIONALITY">anti-goat</ENAMEX> <ENAMEX TYPE="ORGANIZATION">Ig</ENAMEX>,
          <ENAMEX TYPE="ANIMAL">mouse</ENAMEX>-<ENAMEX TYPE="NATIONALITY">anti-</ENAMEX><ENAMEX TYPE="ANIMAL">rat Ig</ENAMEX>, rabbit-<ENAMEX TYPE="NATIONALITY">anti-</ENAMEX><ENAMEX TYPE="ANIMAL">mouse Ig</ENAMEX>, and
          porcine-anti-rabbit <ENAMEX TYPE="ORGANIZATION">Ig-HRP</ENAMEX> [ <TIMEX TYPE="DATE">66</TIMEX> ] . To visualize all
          transferred <ENAMEX TYPE="SUBSTANCE">proteins</ENAMEX>, we used the ECL protein
          biotinylation labeling <ENAMEX TYPE="PER_DESC">modules</ENAMEX> (RPN <TIMEX TYPE="DATE">2202</TIMEX>, <ENAMEX TYPE="ORGANIZATION">Amersham</ENAMEX>) and
          streptavidin alkaline phosphatase (<ENAMEX TYPE="PRODUCT">V020402</ENAMEX>, <ENAMEX TYPE="ORGANIZATION">Amersham</ENAMEX>) in
          accordance with the <ENAMEX TYPE="ORG_DESC">manufacturer</ENAMEX>'s instructions.
        
        
          Ras activation assay
          Only activated p21 Rasis able to bind <TIMEX TYPE="DATE">Raf1</TIMEX>, leading to
          a <NUMEX TYPE="ORDINAL">Raf1</NUMEX>-translocation to the <ENAMEX TYPE="FAC_DESC">cell membrane</ENAMEX>. After
          stimulation with <NUMEX TYPE="CARDINAL">10</NUMEX> nM mature TGFβ 
          <NUMEX TYPE="CARDINAL">1</NUMEX> for <TIMEX TYPE="TIME">10 minutes</TIMEX>, cells were incubated
          in sterile <ENAMEX TYPE="SUBSTANCE">water</ENAMEX> until they lysed. The membrane fraction
          was lysed in <ENAMEX TYPE="LAW">Triton X-100</ENAMEX> lysis buffer. Precipitation
          against Raf1 and analysis for p21 <ENAMEX TYPE="ORGANIZATION">Rasfollowed</ENAMEX>.
        
      
      
        <ENAMEX TYPE="PER_DESC">Authors</ENAMEX>' contributions
        <ENAMEX TYPE="ORGANIZATION">CS</ENAMEX> performed all assays and drafted the manuscript. MPK
        and <ENAMEX TYPE="ORGANIZATION">GMS</ENAMEX> provided suggestions and comments for its
        <ENAMEX TYPE="ORGANIZATION">finalization</ENAMEX>. All <ENAMEX TYPE="PER_DESC">authors</ENAMEX> read and approved the final
        <ENAMEX TYPE="PERSON">manuscript</ENAMEX>.
      
    
  
